NCT05190770 2025-12-03
A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Clinical Trials
11 trialsNCT07192588 2025-09-25
GuARD
Graegis Pharmaceuticals Ltd
Phase 2 Active not recruiting
NCT02142959 2025-06-03
RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE
Biogen
Phase 2 Completed
NCT05693597 2024-02-23
Evaluation of the Effect of Nigella Sativa for the Prophylaxis to Radiation Induced Dermatitis in Breast Cancer Patients
German University in Cairo
Phase 2 Completed
NCT04149522 2023-11-08
Evaluation of Mepitel Film® in Preventing Epidermitis in Patients Receiving Radiation Therapy for Breast Cancer
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Phase 2 Terminated
NCT03494205 2022-05-27
Urticacomp
University of Bern
Phase 2 Completed
NCT03716583 2021-09-10
MELADERM
Herlev Hospital
Phase 2 Completed
NCT02556632 2017-11-06
Curcumin-II
University of Rochester
Phase 2 Completed
NCT02289365 2016-06-15
Orally Administrated JBM-TC4 Prevents Acute Radiodermatitis in Breast Cancer Patients
Joben Bio-Medical Co., Ltd.
Phase 2 Unknown
NCT02249884 2015-12-02
DRCPTR
University of Brasilia
Phase 2 Completed
NCT00445250 2007-03-08
The Role of Calcipotriol as Radioprotector of Skin
Rabin Medical Center
Phase 2 Unknown